HCRTR2 and major depressive disorder: Therefore, Orx receptor antagonists have been investigated as potential targets for the treatment of major depressive disorder (MDD) [32], with a phase 2b study suggesting that an OX2R antagonist had an antidepressant effect on patients with MDD [33].